Skip to content
Screener

CONMED CNMD Q2 2025 earnings

Reported July 30, 2025 · After market close

Revenue$342.3MBeat by $7.7M
EPS$1.15Beat by $0.02
Revenue estimate$334.6M
EPS estimate$1.13

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$336.3M
EPS estimate$1.00

Financials

Q2 2025

Income statement

See full
Revenue$342.3M+3.1%
Gross profit$188.3M+2.5%
Operating income$38.2M-19.0%
Net income$21.4M-28.5%
EPS (diluted)$0.69-28.1%

Balance sheet

See full
Cash & equivalents$33.9M+17.5%
Total debt$884.1M-8.7%
Total equity$1.0B+13.7%
Total assets$2.3B+1.9%

Cash flow

See full
Operating cash flow$29.1M-32.7%
CapEx$5.7M+59.6%
Free cash flow$23.4M-41.1%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.63B-23.4%
Enterprise value$2.49B-19.2%
P/E14.8×-6.8×
P/S1.2×-0.4×

Profitability

See full
Gross margin56.1%+0.7pp
Operating margin13%+0.2pp
Net margin8.3%+0.6pp
FCF margin11.2%-1.3pp

Returns & leverage

See full
Return on equity11.7%-0.2pp
Debt / equity0.9×-0.2×
Current ratio2.2×-0.1×

Segments

By geography

See full
Europe, Middle East & Africa$67.8M+6.4%
Asia Pacific$52.1M+1.3%
Americas (excluding the United States)$31.9M+0.8%

By product

See full
General Surgery$201.6M+4.7%
Orthopedic Surgery$140.7M+0.9%

FAQ

When did CONMED report Q2 2025 earnings?
CONMED (CNMD) reported Q2 2025 earnings on July 30, 2025 after market close.
What were CONMED's Q2 2025 revenue and EPS?
CONMED reported revenue of $342.3M and eps of $1.15 for Q2 2025.
Did CONMED beat estimates in Q2 2025?
Revenue beat the consensus estimate of $334.6M by $7.7M. EPS beat the consensus estimate of $1.13 by $0.02.
How did CONMED's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.5% from $330.7M a year earlier and eps grew 17.3% from $0.98.
Where can I find CONMED's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000816956-25-000026) and the 10-Q periodic report (0000816956-25-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.